MedPath

Innovative Cellular Therapeutics Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

GCC19CART for Patients With Metastatic Colorectal Cancer

Phase 1
Recruiting
Conditions
Colorectal Cancer
Interventions
First Posted Date
2022-04-08
Last Posted Date
2023-06-05
Lead Sponsor
Innovative Cellular Therapeutics Inc.
Target Recruit Count
30
Registration Number
NCT05319314
Locations
🇺🇸

Baylor Scott & White Research Institute, Dallas, Texas, United States

🇺🇸

University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath